5AM Ventures Assists in Launching New Term Sheet Template for Early-Stage Life Science Startups Emerging from Academic Research Labs

News
2022
2021
Archive

November 22, 2022

5AM Ventures Assists in Launching New Term Sheet Template for Early-Stage Life Science Startups Emerging from Academic Research Labs
November 22, 2022

Arvinas Announces ARV-471 Achieves a Clinical Benefit Rate of 38% in Evaluable Patients and Continues to Show a Favorable Tolerability Profile in its Phase 2 Expansion Trial (VERITAC)
November 22, 2022

scPharmaceuticals Announces Pricing of $50 Million Public Offering
November 21, 2022

scPharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock
November 17, 2022

Escient Pharmaceuticals Initiates Phase 2 PACIFIC Study Evaluating EP547, An Oral MRGPRX4 Antagonist, in Subjects with Cholestatic Pruritus
November 17, 2022

Escient Pharmaceuticals Strengthens Leadership Team with Key New Hires
November 15, 2022

Nouscom Announces First Patient Dosed in Phase 2 Randomized Trial with NOUS-209, an ‘off-the shelf’ Neoantigen Cancer Immunotherapy in dMMR/MSI-High Metastatic Colorectal Cancer
November 14, 2022

Artiva Biotherapeutics Presents Preclinical Data for AB-101, an Optimized Allogeneic NK Cell Therapy Candidate, at SITC 2022 Annual Meeting
November 14, 2022

Rallybio Announces Pricing of $50 Million Public Offering
November 10, 2022

Rallybio Announces Proposed Public Offering

1
2
3
…
101
Next Page »

© 2022 5AM Venture Management LLC